Brought to you by:
CVRx announces new CPT Category I codes for Barostim baroreflex activation therapy
CVRx, the company behind the Barostim baroreflex activation therapy system, recently announced that the American Medical Association (AMA) has accepted new Current Procedural Terminology (CPT) Category I codes for the device, which treats the symptoms of heart failure. The decision…
SVS member picks up prestigious American Heart Association accolade for scientific work
A prominent surgeon-scientist and Society for Vascular Surgery (SVS) member is the 2024 recipient of the American Heart Association (AHA) Joseph A. Vita Award, which recognizes published work that has had a transformative impact on basic, translational or clinical cardiovascular…
Novel RCT framework set to improve design and reporting of endovascular infrainguinal lower-limb interventions for PAD
Pilot testing has shown that a new framework—dubbed Endo-STAR—can be used to describe and standardise endovascular interventions for peripheral arterial disease (PAD) within a randomised controlled trial (RCT) protocol and monitor adherence to the protocol over the course of a…
Pulse IVL system US pivotal trial enrolls first patient
Amplitude Vascular Systems (AVS) recently announced that it has enrolled the first patient in its U.S. pivotal trial for pulsatile intravascular lithotripsy (IVL) therapy. A press release notes that the POWER PAD II clinical study will evaluate the safety and…
‘Investing in the people of vascular surgery’
Outgoing Midwestern Vascular Surgical Society (MVSS) President Bernadette Aulivola, MD, underscored the importance of “investing in the people of vascular surgery—those learning about it and those progressing through their careers”—for the future of the specialty. At the heart of this…
Contego Medical’s Neuroguard IEP system receives US FDA approval for carotid revascularisation
Contego Medical today announced the US Food and Drug Administration’s (FDA) premarket approval (PMA) of the Neuroguard IEP system for carotid revascularisation. The company shares in a press release that clinical studies of the Neuroguard IEP system, including the PERFORMANCE…
Research suggests potential link between strenuous physical activity and increased VTE risk in men
Published in the Journal of Thrombosis and Thrombolysis, new research with a follow-up of 27 years has found an association between high levels of physical activity (PA) and an elevated risk of venous thromboembolism (VTE). The research, led by Per…
Bioprosthetic venous valve imparts sustained clinical improvement at one year regardless of CEAP category
A new paper that drills into the impact of a novel bioprosthetic venous valve replacement by CEAP (Clinical, Etiological, Anatomical and Pathophysiological) classification shows sustained clinical improvement regardless of grading, with patients classed as C4b exhibiting greater resolution of symptoms…
InspireMD receives IDE approval from FDA for CGUARDIANS II pivotal trial
InspireMD has announced that the Food and Drug Administration (FDA) approval of the company’s investigational device exemption (IDE) application to initiate the CGUARDIANS II pivotal study of its CGuard Prime 80cm carotid stent system during transcarotid artery revascularization (TCAR) procedures.…
Smoking: BEST-CLI trial points to protective effect against MALE in those undergoing open bypass over endovascular intervention
An analysis of the BEST-CLI randomized controlled trial (RCT) found that smokers with chronic limb-threatening ischemia (CLTI) should be preferentially treated with open bypass over endovascular intervention. Researchers from the University of California San Diego (UCSD) looked at BEST-CLI patients…